{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:44:35Z","timestamp":1794638675442,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008700","name":"Centre International de Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41591-025-03793-6","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T11:01:59Z","timestamp":1751886119000},"page":"3020-3027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":124,"title":["Global lifetime estimates of expected and preventable gastric cancers across 185 countries"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2491-5099","authenticated-orcid":false,"given":"Jin Young","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2425-7591","authenticated-orcid":false,"given":"Damien","family":"Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina J.","family":"Alberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-333X","authenticated-orcid":false,"given":"Gary","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7322-1862","authenticated-orcid":false,"given":"Iacopo","family":"Baussano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"key":"3793_CR1","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/jjco\/hyy077","volume":"48","author":"C Hamashima","year":"2018","unstructured":"Hamashima, C.; Systematic Review Group and Guideline Development Group for Gastric Cancer Screening Guidelines.Update version of the Japanese Guidelines for Gastric Cancer Screening. Jpn. J. Clin. Oncol. 48, 673\u2013683 (2018).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"3793_CR2","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1053\/j.gastro.2017.01.029","volume":"152","author":"JK Jun","year":"2017","unstructured":"Jun, J. K. et al. Effectiveness of the Korean National Cancer Screening Program in reducing gastric cancer mortality. Gastroenterology 152, 1319\u20131328 (2017).","journal-title":"Gastroenterology"},{"key":"3793_CR3","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"3793_CR4","doi-asserted-by":"publisher","first-page":"101404","DOI":"10.1016\/j.eclinm.2022.101404","volume":"47","author":"E Morgan","year":"2022","unstructured":"Morgan, E. et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study. EClinicalMedicine 47, 101404 (2022).","journal-title":"EClinicalMedicine"},{"key":"3793_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036288","volume":"8","author":"CP Howson","year":"1986","unstructured":"Howson, C. P., Hiyama, T. & Wynder, E. L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol. Rev. 8, 1\u201327 (1986).","journal-title":"Epidemiol. Rev."},{"key":"3793_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S2468-1253(21)00064-9","volume":"6","author":"SC Shah","year":"2021","unstructured":"Shah, S. C. Gastric cancer: a neglected threat to racial and ethnic minorities in the USA. Lancet Gastroenterol. Hepatol. 6, 266\u2013267 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"3793_CR7","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.2014.10498","volume":"312","author":"R Herrero","year":"2014","unstructured":"Herrero, R., Parsonnet, J. & Greenberg, E. R. Prevention of gastric cancer. JAMA 312, 1197\u20131198 (2014).","journal-title":"JAMA"},{"key":"3793_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold, M. et al. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut 69, 823\u2013829 (2020).","journal-title":"Gut"},{"key":"3793_CR9","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1001\/jama.2010.496","volume":"303","author":"WF Anderson","year":"2010","unstructured":"Anderson, W. F. et al. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA 303, 1723\u20131728 (2010).","journal-title":"JAMA"},{"key":"3793_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jnci\/djx262","volume":"110","author":"WF Anderson","year":"2018","unstructured":"Anderson, W. F. et al. The changing face of noncardia gastric cancer incidence among US non-Hispanic whites. J. Natl Cancer Inst. 110, 608\u2013615 (2018).","journal-title":"J. Natl Cancer Inst."},{"key":"3793_CR11","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/ijc.30835","volume":"141","author":"G Luo","year":"2017","unstructured":"Luo, G. et al. Global patterns and trends in stomach cancer incidence: age, period and birth cohort analysis. Int. J. Cancer 141, 1333\u20131344 (2017).","journal-title":"Int. J. Cancer"},{"key":"3793_CR12","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/S2214-109X(19)30488-7","volume":"8","author":"C de Martel","year":"2020","unstructured":"de Martel, C., Georges, D., Bray, F., Ferlay, J. & Clifford, G. M. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob. Health 8, e180\u2013e190 (2020).","journal-title":"Lancet Glob. Health"},{"key":"3793_CR13","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens. Part B: Biological Agents Vol. 100B (IARC, 2012)."},{"key":"3793_CR14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2024.12.033","author":"AC Ford","year":"2025","unstructured":"Ford, A. C., Yuan, Y., Park, J. Y., Forman, D. & Moayyedi, P. Eradication therapy to prevent gastric cancer in Helicobacterpylori-positive individuals: systematic review and meta-analysis of randomized controlled trials and observational studies. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2024.12.033 (2025).","journal-title":"Gastroenterology"},{"key":"3793_CR15","unstructured":"Park, J. Y. et al. Summary of IARC Working Group Meeting on Helicobacter pylori eradication as a strategy for preventing gastric cancer. In IARC Helicobacter pylori Working Group. Helicobacter pylori Eradication as a Strategy for Preventing Gastric Cancer (IARC Working Group Report No. 8) 1\u20134 (IARC, 2014)."},{"key":"3793_CR16","unstructured":"Europe\u2019s Beating Cancer Plan\u2014Communication from the Commission to the European Parliament and the Council health.ec.europa.eu\/system\/files\/2022-02\/eu_cancer-plan_en_0.pdf (European Commission, 2021)."},{"key":"3793_CR17","doi-asserted-by":"publisher","first-page":"7295","DOI":"10.1016\/j.vaccine.2018.01.001","volume":"37","author":"P Sutton","year":"2019","unstructured":"Sutton, P. & Boag, J. M. Status of vaccine research and development for Helicobacter pylori. Vaccine 37, 7295\u20137299 (2019).","journal-title":"Vaccine"},{"key":"3793_CR18","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.20892\/j.issn.2095-3941.2022.0655","volume":"19","author":"H Xu","year":"2022","unstructured":"Xu, H. & Li, W. Early detection of gastric cancer in China: progress and opportunities. Cancer Biol. Med. 19, 1622\u20131628 (2022).","journal-title":"Cancer Biol. Med."},{"key":"3793_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gutjnl-2020-322200","volume":"70","author":"T-H Chiang","year":"2021","unstructured":"Chiang, T.-H. et al. Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands. Gut 70, 243\u2013250 (2021).","journal-title":"Gut"},{"key":"3793_CR20","doi-asserted-by":"publisher","first-page":"e12415","DOI":"10.1111\/hel.12415","volume":"22","author":"M Tsuda","year":"2017","unstructured":"Tsuda, M. et al. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan. Helicobacter 22, e12415 (2017).","journal-title":"Helicobacter"},{"key":"3793_CR21","doi-asserted-by":"publisher","first-page":"100370","DOI":"10.1016\/j.lansea.2024.100370","volume":"24","author":"T Dorji","year":"2024","unstructured":"Dorji, T. et al. Population-level cancer screening and cancer care in Bhutan, 2020\u20132023: a review. Lancet Reg. Health Southeast Asia 24, 100370 (2024).","journal-title":"Lancet Reg. Health Southeast Asia"},{"key":"3793_CR22","first-page":"100608","volume":"27","author":"A Riquelme","year":"2023","unstructured":"Riquelme, A. et al. Recommendations for gastric cancer prevention and control in the Americas. Lancet Reg. Health Am. 27, 100608 (2023).","journal-title":"Lancet Reg. Health Am."},{"key":"3793_CR23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","volume":"160","author":"MB Piazuelo","year":"2021","unstructured":"Piazuelo, M. B. et al. The Colombian chemoprevention trial: 20-year follow-up of a cohort of patients with gastric precancerous lesions. Gastroenterology 160, 1106\u20131117 (2021).","journal-title":"Gastroenterology"},{"key":"3793_CR24","unstructured":"SEER*Explorer: An Interactive Website for SEER Cancer Statistics (Surveillance Research Program, National Cancer Institute, accessed 17 March 2025); seer.cancer.gov\/statistics-network\/explorer\/"},{"key":"3793_CR25","doi-asserted-by":"publisher","first-page":"e13153","DOI":"10.1111\/hel.13153","volume":"29","author":"S Mashiko","year":"2024","unstructured":"Mashiko, S. et al. Helicobacter pylori management in Africa: a survey of diagnostic, treatment, and related resources. Helicobacter 29, e13153 (2024).","journal-title":"Helicobacter"},{"key":"3793_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/gut.33.4.429","volume":"33","author":"C Holcombe","year":"1992","unstructured":"Holcombe, C. Helicobacter pylori: the African enigma. Gut 33, 429\u2013431 (1992).","journal-title":"Gut"},{"key":"3793_CR27","doi-asserted-by":"publisher","first-page":"e1489","DOI":"10.1016\/S2214-109X(20)30358-2","volume":"8","author":"MM Coates","year":"2020","unstructured":"Coates, M. M. et al. Burden of non-communicable diseases from infectious causes in 2017: a modelling study. Lancet Glob. Health 8, e1489\u2013e1498 (2020).","journal-title":"Lancet Glob. Health"},{"key":"3793_CR28","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1080\/14737159.2023.2277377","volume":"23","author":"J Gu","year":"2023","unstructured":"Gu, J. et al. A systematic review and meta-analysis on the relative and attributable risk of Helicobacter pylori infection and cardia and non-cardia gastric cancer. Expert Rev. Mol. Diagn. 23, 1251\u20131261 (2023).","journal-title":"Expert Rev. Mol. Diagn."},{"key":"3793_CR29","doi-asserted-by":"publisher","first-page":"e888","DOI":"10.1016\/S2468-2667(21)00164-X","volume":"6","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. The relative and attributable risks of cardia and non-cardia gastric cancer associated with Helicobacter pylori infection in China: a case\u2013cohort study. Lancet Public Health 6, e888\u2013e896 (2021).","journal-title":"Lancet Public Health"},{"key":"3793_CR30","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","volume":"30","author":"K-F Pan","year":"2024","unstructured":"Pan, K.-F. et al. Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. Nat. Med. 30, 3250\u20133260 (2024).","journal-title":"Nat. Med."},{"key":"3793_CR31","doi-asserted-by":"publisher","first-page":"101735","DOI":"10.1016\/j.bpg.2021.101735","volume":"50\u201351","author":"I Lansdorp-Vogelaar","year":"2021","unstructured":"Lansdorp-Vogelaar, I. et al. Cost-effectiveness of prevention and early detection of gastric cancer in Western countries. Best Pract. Res. Clin. Gastroenterol. 50\u201351, 101735 (2021).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"3793_CR32","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","volume":"69","author":"AC Ford","year":"2020","unstructured":"Ford, A. C., Yuan, Y. & Moayyedi, P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut 69, 2113\u20132121 (2020).","journal-title":"Gut"},{"key":"3793_CR33","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1053\/j.gastro.2022.05.027","volume":"163","author":"AC Ford","year":"2022","unstructured":"Ford, A. C., Yuan, Y. & Moayyedi, P. Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: a meta-analysis beyond 10 years of follow-up. Gastroenterology 163, 754\u2013756 (2022).","journal-title":"Gastroenterology"},{"key":"3793_CR34","unstructured":"European Commission, Directorate-General for Research and Innovation, Group of Chief Scientific Advisors. Cancer Screening in the European Union (Publications Office of the European Union, 2022)."},{"key":"3793_CR35","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/gutjnl-2024-332705","volume":"73","author":"M Leja","year":"2024","unstructured":"Leja, M. Where are we with gastric cancer screening in Europe in 2024? Gut 73, 2074\u20132082 (2024).","journal-title":"Gut"},{"key":"3793_CR36","unstructured":"Park, J. Y. (ed.) Population-Based Helicobacter pylori Screen-and-Treat Strategies for Gastric Cancer Prevention: Guidance on Implementation (IARC Working Group Report No. 12) (IARC, 2025)."},{"key":"3793_CR37","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","volume":"386","author":"M Zeng","year":"2015","unstructured":"Zeng, M. et al. Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 386, 1457\u20131464 (2015).","journal-title":"Lancet"},{"key":"3793_CR38","doi-asserted-by":"publisher","first-page":"e13034","DOI":"10.1111\/hel.13034","volume":"29","author":"K Yunle","year":"2024","unstructured":"Yunle, K., Tong, W., Jiyang, L. & Guojun, W. Advances in Helicobacter pylori vaccine research: from candidate antigens to adjuvants\u2014a review. Helicobacter 29, e13034 (2024).","journal-title":"Helicobacter"},{"key":"3793_CR39","doi-asserted-by":"publisher","first-page":"101733","DOI":"10.1016\/j.bpg.2021.101733","volume":"50\u201351","author":"JY Park","year":"2021","unstructured":"Park, J. Y. & Herrero, R. Recent progress in gastric cancer prevention. Best Pract. Res. Clin. Gastroenterol. 50\u201351, 101733 (2021).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"3793_CR40","unstructured":"Gavi, the Vaccine Alliance. Annual Progress Report 2022 (Gavi, 2022)."},{"key":"3793_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/gutjnl-2022-328233","volume":"72","author":"M Li","year":"2023","unstructured":"Li, M. et al. Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut 72, 846\u2013854 (2023).","journal-title":"Gut"},{"key":"3793_CR42","unstructured":"Ferlay, J. et al. Global Cancer Observatory: Cancer Today (Version 1.1) (International Agency for Research on Cancer, accessed 2 February 2025); gco.iarc.who.int\/today"},{"key":"3793_CR43","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2025","unstructured":"Filho, A. M. et al. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int. J. Cancer 156, 1336\u20131346 (2025).","journal-title":"Int. J. Cancer"},{"key":"3793_CR44","unstructured":"Bray, F. et al. (eds) Cancer Incidence in Five Continents, Vol. XII (IARC CancerBase No. 19) (IARC, 2023)."},{"key":"3793_CR45","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1136\/gutjnl-2020-321600","volume":"69","author":"M Arnold","year":"2020","unstructured":"Arnold, M., Ferlay, J., van Berge Henegouwen, M. I. & Soerjomataram, I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut 69, 1564\u20131571 (2020).","journal-title":"Gut"},{"key":"3793_CR46","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/ijc.28999","volume":"136","author":"M Plummer","year":"2015","unstructured":"Plummer, M., Franceschi, S., Vignat, J., Forman, D. & de Martel, C. Global burden of gastric cancer attributable to Helicobacter pylori. Int. J. Cancer 136, 487\u2013490 (2015).","journal-title":"Int. J. Cancer"},{"key":"3793_CR47","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S2468-2667(21)00046-3","volume":"6","author":"M Bonjour","year":"2021","unstructured":"Bonjour, M. et al. Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis. Lancet Public Health 6, e510\u2013e521 (2021).","journal-title":"Lancet Public Health"},{"key":"3793_CR48","unstructured":"United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects 2022 population.un.org\/wpp\/ (UN, 2022)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03793-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03793-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03793-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:09:53Z","timestamp":1788516593000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03793-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["3793"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03793-6","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"11 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}